Genomic & Biopharma NewsHarnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals. For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
|ORB Company Blog, 2017-03-31 21:41:45|
More bad Alzheimer’s news as FDA device panel is not persuaded by Neuronix’s TMS study
An agency advisory panel voted against recommending clearance for Neuronix's transcranial magnetic stimulation device, which targets the memory and learning centers of the brain during cognitive therapy sessions.
|Fierce Biotech, 2019-03-22 20:35:43|
ORB Employees Participate in 2019 Martin Luther King Day Event
ORB employees get a rare break from the lab on January 21, 2019. A group of Ocean Ridge Biosciences employees stepped out of the lab on a beautiful South Florida winter day to take part in an event honoring Martin Luther King. We got our hands dirty planting some flowers and shrubs at a local park in Deerfield Beach.
|ORB Company News, 2019-01-22 23:24:59|
Anti-TB drugs can increase susceptibility to Mtb reinfection
Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
|News Medical Life Sciences, 2019-03-22 20:07:55|
Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
New research identifies guidelines for prioritizing the treatment of hepatitis C infections in the U.S. prison system, resulting in a significant improvement in health outcomes of incarcerated persons while simultaneously reducing new infections in the society.
|News Medical Life Sciences, 2019-03-22 20:01:53|
Antidepressant drugs may not work when neurons are out of shape
elective serotonin reuptake inhibitors are the most commonly prescribed medication for major depressive disorder, yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with MDD.
|News Medical Life Sciences, 2019-03-22 19:56:09|
New model could revolutionize the way researchers investigate spread of pathogens
A sophisticated new analysis tool developed by Florida State University scientists may signal a new era in the study of population genetics.
|News Medical Life Sciences, 2019-03-22 19:35:15|
MSU professor receives NSF CAREER grant for biosensor diagnostics
One day, a technician in a small, rural hospital may be able to reliably diagnose breast cancer, Alzheimer's disease or traumatic brain injury using a tab of paper that would change color like a pH strip dipped in vinegar.
|News Medical Life Sciences, 2019-03-22 19:26:49|
FDA Approves Tecentriq/Chemo for Newly Diagnosed Extensive-stage SCLC
|Immuno-Oncology News, 2019-03-22 19:17:21|
High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
A diet high in fats and sugars is known for its unhealthy effects on the heart. Scientists now have found that a high-fat, high-sugar diet in mouse mothers before and during pregnancy causes problems in the hearts of their offspring, and that such problems are passed down at least three generations, even if the younger generations only eat a standard mouse chow diet.
|News Medical Life Sciences, 2019-03-22 19:13:38|
FDA stiff-arms Sanofi and Lexicon's Type 1 diabetes hopeful Zynquista
When a panel of experts couldn’t agree on the merit of Sanofi and Lexicon’s SGLT1/2 inhibitor Zynquista for Type 1 diabetes, Sanofi stood behind the drug. But now the FDA has handed down its decision against it.
|Fierce Pharma, 2019-03-22 18:44:07|